Accelerate to Discover

Back to filter

Related topics

From thousands of SVS to a handful of candidate genes

BioNano Genomics

Mar 1, 2018

Bionano’s Variant Annotation Pipeline (VAP) saves researchers valuable time (and frustration) by annotating structural...

Protectome analysis: A new selective tool for bacterial vaccine discovery

Acea Biosciences

Feb 28, 2018

New generation vaccines are in demand to include only the key antigens sufficient to confer protective immunity among...

Follow biological processes in vivo at the cellular level

Mauna Kea Technologies

Feb 27, 2018

Cellvizio Lab uses unique probe-based Confocal Laser Endomicroscopy technology. Watch this recorded webinar to learn...

A novel real time imaging platform to quantify Macrophage Phagocytosis


Feb 26, 2018

Phagocytosis is a specific form of endocytosis by which cells engulf and internalize solid matter. Macrophages,...

Mar 18, 2018

How to build the largest genome ever, in 3 easy steps

BioNano Genomics

Feb 23, 2018

Here we report the sequencing and assembly of the 32-gigabase-pair axolotl genome using an approach that combined...

High-throughput observation of molecular motor activity & dynamics


Feb 21, 2018

With LUMICKS’ C-Trap, it is possible to observe myosin activity,the processive motion, the binding kinetics along...


Precision X-Ray

Feb 20, 2018

The X-RAD SmART Image Guided Irradiator for small animals provides the most advanced and accurate treatment...

Mar 18, 2018

xxcloud – thermal cycler software

BJS Biotechnologies

Feb 16, 2018

Tired of waiting in line to use a qPCR system? The wait is over… the xxcloud is here! The xxcloud is exciting new...

Show all topics (10)

Intelligent antibody discovery

Apr 4, 2016

With the promise of better specificity and safety, antibody-based drugs are a powerful tool for treating disease. But finding the best candidates to move through development can be time consuming and expensive. It’s not just about screening to find the highest-affinity binder, it’s also about finding the antibody that can promote the desired biological response while avoiding off-target binding and toxicity.

The iQue Screener speeds your antibody discovery programs by reducing screening time while increasing the amount and kind of data you can collect. In just a fraction of the time it takes to do a high-throughput ELISA—and using far less target protein—the iQue Screener not only provides quantitative binding information, it can also deliver data from cell-based assays that report on functions such as membrane integrity, cytokine release, and more. This comprehensive data set helps you make more informed decisions about potential leads faster, reducing discovery time, reducing discovery costs, and conserving valuable reagents.

Product news

Related technologies: Conventional Flow Cytometry

Brand profile


IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic